Wednesday, May 1, 2024
Home Client Page 34

Client

    Most popular

    China Remains at Risk to Future MonkeyPox Outbreaks.

    Client Editor / Curator -
    GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.

    IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...

    Client Editor / Curator -
    Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge! Taking advantage of post reverse-split investor...

    Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

    Client Editor / Curator -
    Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...

    GeoVax to Present at World Vaccine Congress, Thursday April 4th.

    Client Editor / Curator -
    Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation non-MRNA Covid-19 vaccine...

    Adding Asia Broadband (AABB) to Speculative Watch List.

    Client Editor / Curator -
    Asia Broadband, Gold Play With Digital Currency (NFT) Twist The last speculative stock trading under $0.05, that we...

    And We Have a $26.4 Billion Winning Trifecta!

    Client Editor / Curator -
    THREE PREVIOUS WINNERS* Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired...
    1...323334Page 34 of 34

    Latest article

    Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

    Client Editor / Curator -
    Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

    Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

    Client Editor / Curator -
    CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

    GeoVax (GOVX) Launches Vaccine Manufacturing System.

    2024 Watch List Editor / Curator -
    GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.